Otsuka Pakistan Limited (PSX:OTSU)
450.00
+13.75 (3.15%)
At close: Nov 6, 2026
Otsuka Pakistan Revenue
Otsuka Pakistan had revenue of 1.15B PKR in the quarter ending September 30, 2026, with 6.62% growth. This brings the company's total for the last twelve months to 4.18B, up 3.40% year-over-year. In the fiscal year ending June 30, 2026, Otsuka Pakistan had annual revenue of 4.11B with 8.77% growth. That makes Otsuka Pakistan the 35,386th largest company in the world by revenue and 275th in Pakistan.
Revenue (ttm)
4.18B
Revenue Growth
+3.40%
P/S Ratio
1.26
Revenue / Employee
10.56M
Employees
396
Market Cap
5.45B
Revenue by Geography
- Pakistan 4.04B 98.1%
- Afghanistan 76.06M 1.9%
Fiscal year ended Jun 30, 2026 See the full Otsuka Pakistan breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.11B | 331.59M | 8.77% |
| Jun 30, 2025 | 3.78B | 615.65M | 19.46% |
| Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
| Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
| Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.83B |
| GlaxoSmithKline Pakistan | 69.53B |
| The Searle Company | 38.29B |
| Highnoon Laboratories | 28.89B |
| AGP Limited | 26.52B |
| Ferozsons Laboratories | 25.09B |
| Citi Pharma | 14.22B |
| Macter International | 12.50B |